The Era of Rationing Begins: "By December, the Food and Drug Administration (FDA) is expected to revoke approval of the drug Avastin for the treatment of advanced breast cancer. U.S. Senator David Vitter has described the anticipated move as 'the beginning of a slippery slope leading to more and more rationing under the government takeover of health care,' says Sally C. Pipes, president and CEO of the Pacific Research Institute.
* The FDA claims its decision won't be based on cost, but Avastin isn't cheap -- a full regimen costs about $100,000 a year.
* Avastin has proven to be a wonder drug for countless women with stage IV breast cancer, slowing the disease's progression and dramatically extending life.
* But when no significant increase in 'overall survivability' was reported this summer, an FDA advisory panel recommended that Avastin's approval be withdrawn."
See original work for more on this and other stories.
No comments:
Post a Comment
Spamming will be removed.
Due to spamming. Comments need to be moderated. Your post will appear after moderated regardless of your views as long as they are not abusive in nature. Consistent abusive posters will not be viewed but deleted.
Note: Only a member of this blog may post a comment.